Stiripentol for dravet syndrome: is it worth it? - PubMed (original) (raw)
Stiripentol for dravet syndrome: is it worth it?
Eric Kossoff. Epilepsy Curr. 2014 Jan.
No abstract available
Similar articles
- Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
Buck ML, Goodkin HP. Buck ML, et al. Ann Pharmacother. 2019 Nov;53(11):1136-1144. doi: 10.1177/1060028019856008. Epub 2019 Jun 6. Ann Pharmacother. 2019. PMID: 31167540 Clinical Trial. - Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
Wirrell EC, Laux L, Franz DN, Sullivan J, Saneto RP, Morse RP, Devinsky O, Chugani H, Hernandez A, Hamiwka L, Mikati MA, Valencia I, Le Guern ME, Chancharme L, de Menezes MS. Wirrell EC, et al. Epilepsia. 2013 Sep;54(9):1595-604. doi: 10.1111/epi.12303. Epub 2013 Jul 12. Epilepsia. 2013. PMID: 23848835 - Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome.
Yıldız EP, Ozkan MU, Uzunhan TA, Bektaş G, Tatlı B, Aydınlı N, Çalışkan M, Özmen M. Yıldız EP, et al. J Child Neurol. 2019 Jan;34(1):33-37. doi: 10.1177/0883073818811538. Epub 2018 Oct 26. J Child Neurol. 2019. PMID: 30362398 - Stiripentol for the treatment of seizures in Dravet syndrome.
Eschbach K, Knupp KG. Eschbach K, et al. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. doi: 10.1080/17512433.2019.1605904. Epub 2019 Apr 24. Expert Rev Clin Pharmacol. 2019. PMID: 31017478 Review. - Current therapeutic procedures in Dravet syndrome.
Chiron C. Chiron C. Dev Med Child Neurol. 2011 Apr;53 Suppl 2:16-8. doi: 10.1111/j.1469-8749.2011.03967.x. Dev Med Child Neurol. 2011. PMID: 21504427 Review.
References
- Scheffer IE. Diagnosis and long-term course of Dravet syndrome. Eur J Paediatr Neurol. 2012;16(suppl 1):S5–S8. - PubMed
- Chiron C, Dulac O. The pharmacologic treatment of Dravet syndrome. Epilepsia. 2011;52(suppl 2):72–75. - PubMed
- Laux L, Blackford R. The ketogenic diet in Dravet syndrome. J Child Neurol. 2013;8:1041–1044. - PubMed
- Levy RH, Lin HS, Blehaut HM, Tor JA. Pharmacokinetics of stiripentol in normal man: Evidence of nonlinearity. J Clin Pharmacol. 1983;23:523–533. - PubMed
- Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356:1638–1642. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources